Menu Close

Trending

An inside peek into pharma marketing at PM Society learning event – part i
SABCS: AZ’s oral SERD data may “relaunch enthusiasm” for class
SABCS: New ADC from AZ and Daiichi shows promise in breast cancer
PharmStars digital health accelerator names its second class of 2022
Autolus announces primary endpoint met in FELIX trial, prices public offering

Life Sciences Sector Deal

Brexit-life-sciences-sector-deal-5

Market Access/ Views & Analysis/ Views and analysis

UK pharma negotiating choppy seas during Brexit, says ABPI’s outgoing president Nordkamp

, , , 0 Comment

pharmaphorum caught up with Erik Nordkamp, outgoing president of the Association of the British Pharmaceutical Industry (ABPI), who

X
UK pharma negotiating choppy seas during Brexit, says ABPI’s outgoing president Nordkamp
https://pharmaphorum.com/views-analysis-market-access/uk-pharma-negotiating-choppy-seas-during-brexit-says-abpis-outgoing-president-nordkamp/
 
IQVIA_webinar_holding_slide-21_01_2019

Debates & Insight/ Market Access/ Webinars/ Webinars in home page/ Webinars On demand

The 2nd Life Sciences Sector Deal and the NHS 10 Year Plan

, , , , , 0 Comment

Overview Brexit uncertainty isn’t going away any time soon – but it’s important to remember that the UK

X
The 2nd Life Sciences Sector Deal and the NHS 10 Year Plan
https://pharmaphorum.com/market-access-2/the-2nd-life-sciences-sector-deal-and-the-nhs-10-year-plan/
digital innovation future health

Articles/ Healthcare/ Pharma Market Access/ UK & Europe/ Views and analysis

Could the PPRS support a changing growth and innovation agenda?

, , , , , 0 Comment

Has the PPRS delivered on the aim to support the government’s growth and innovation agenda?

X
Could the PPRS support a changing growth and innovation agenda?
https://pharmaphorum.com/views-and-analysis/pprs-support-changing-growth-innovation-agenda/

Login

CONTINUE TO SITE >
X
Close in 10 seconds